Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination of regorafenib and acetylsalicylic acid for treating cancer

US Patent 10898500 · Granted Jan 26, 2021

Assignee

Inventors

View full patent text on Google Patents →